Breakdown | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 49.14B | 49.05B | 44.81B | 39.35B | 35.59B |
Gross Profit | 13.17B | 12.73B | 10.41B | 9.89B | 8.76B |
EBITDA | 5.09B | 5.31B | 3.23B | 3.17B | 7.57B |
Net Income | 2.46B | 2.55B | 1.17B | 1.14B | 4.22B |
Balance Sheet | |||||
Total Assets | 70.17B | 72.39B | 69.56B | 68.42B | 69.41B |
Cash, Cash Equivalents and Short-Term Investments | 8.93B | 8.78B | 7.01B | 6.79B | 7.67B |
Total Debt | 10.65B | 13.57B | 14.96B | 16.22B | 17.86B |
Total Liabilities | 29.60B | 34.09B | 34.49B | 34.42B | 36.45B |
Stockholders Equity | 39.84B | 37.62B | 34.46B | 33.41B | 32.41B |
Cash Flow | |||||
Free Cash Flow | 3.87B | 3.42B | 1.59B | 1.02B | -805.00M |
Operating Cash Flow | 4.65B | 4.17B | 2.67B | 2.07B | 2.76B |
Investing Cash Flow | -815.00M | -580.00M | -821.00M | -917.00M | 3.30B |
Financing Cash Flow | -3.75B | -1.88B | -1.67B | -2.13B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
86 Outperform | ¥33.65B | 12.98 | 4.16% | -1.69% | -2.96% | ||
61 Neutral | $17.75B | 12.51 | -5.49% | 3.06% | 1.43% | -14.10% | |
― | $19.38B | 40.19 | 31.25% | 0.74% | ― | ― | |
79 Outperform | ¥27.78B | 13.71 | 4.12% | 2.12% | 56.08% | ||
76 Outperform | ¥259.84B | 15.07 | 1.51% | 6.92% | 46.32% | ||
73 Outperform | ¥37.53B | 11.87 | 2.73% | 2.31% | 2.20% | ||
67 Neutral | ¥7.69B | 14.88 | 2.90% | -1.58% | -16.57% |